Navigation Links
Vion Reports 2008 Third Quarter and Nine-Month Results
Date:11/3/2008

vo poor-risk acute myelogenous leukemia. Clinical trials of laromustine (Cloretazine(R), VNP40101M) with cytarabine in elderly patients with acute myelogenous leukemia, with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to file a New Drug Application or obtain regulatory approval for its products, particularly laromustine (Cloretazine,VNP40101M), delays in the regulatory approval process or delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not predictive of safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2007 and Form 10-Q for the quarter ended June 30, 2008. In particular, there can be no assurance
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008
2. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
3. NxStage Reports Third Quarter 2008 Financial Results
4. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
5. The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
6. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. Nuvelo Reports Third Quarter 2008 Financial Results
9. Claimsnet.com Reports Third Quarter 2008 Results
10. Remuda Ranch Reports Many Individuals With Eating Disorders Are Not Getting Help They Need
11. Palomar Medical Reports Financial Results for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... (PRWEB) May 25, 2013 While some ... those who have died serving our Country, many others ... prolonged partying and recklessness. The DUI attorneys at MacGregor ... DUI checklist to help keep this weekend’s party-goers out ... System , there were more than 950 fatal alcohol-related ...
(Date:5/25/2013)... May 25, 2013 An experienced Chandler ... in partnership with JD Media Surge, LLC. , ... now available and, depending on the treatment, can be ... routine visit, the best method will be chosen for ... during a visit. A special peroxide-based whitening gel is ...
(Date:5/25/2013)... A disorder of the nerves, Diabetic ... According to neuropathy expert doctor Helen C Lin, on ... the disorder affects almost 50% of all Diabetic patients, ... The high blood sugar levels in the body are ... it usually tend to have abnormally high blood sugar ...
(Date:5/25/2013)... 25 (HealthDay News) -- Animals make great companions for senior ... in the car are far more likely to crash than ... The new study included 2,000 licensed drivers aged 70 ... asked how often they drove with their pet in the ... the crash risk was twice as high as among those ...
(Date:5/25/2013)... TX (PRWEB) May 25, 2013 Studies ... those who are carrying excessive weight and their inability ... for many, simply losing weight can naturally relieve many ... found that improvement in sleep quality was significantly associated ... six month study dated November 6th, 2012, ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers Newly Improved hCG Diet Plans Capable of Delivering Better Sleep 2
... a method for male contraception that is effective, reversible ... new study accepted for publication in The Endocrine Society,s ... JCEM ). , "For couples who can not, ... have been limited to vasectomy, condom and withdrawal," said ...
... New England States, Enhancement of Health Coverage Programs ... from HealthLeaders-InterStudyNASHVILLE, Tenn., May 4 HealthLeaders-InterStudy, a ... that while Massachusetts, healthcare reform has been successful ... continue the program amid the recession and spiraling ...
... National child advocacy organization grades child health care reform ... days milestone, President Obama continues to enjoy high ratings ... his administration and 111th Congress score an "incomplete" for ... Monday by Voices for America,s Children, a premier national ...
... for organizations in SE Michigan . Event ... professionals. Increase wellness, decrease insurance costs, improve morale, ... 4 Cambridge Employee Benefits, a division of ... corporate Wellness & HR Summit May 21, 2009.The ...
... Prepared with Flu Preparedness Information from American Red CrossCHICAGO, ... are closing down due to the swine flu (H1N1 ... safe and reliable in-home caregiver options. In response ... a 20 percent discount to Sittercity.com for the month ...
... Month draws attention to urgency in preventing stroke and supporting 6 million ... ... -- This year nearly 795,000 people will have a stroke, leaving a ... according to National Stroke Association , which is observing National Stroke ...
Cached Medicine News:Health News:Massachusetts Healthcare Reform Cost Containment Strategy Featured in New Report 2Health News:Kids Group Scores Obama, Congress in 100 Days Report Card 2Health News:Cambridge Employee Benefits to Host Corporate Wellness & HR Summit 2Health News:In-Home Caregivers Standing by Nationwide to Support Increased Need Due to Swine Flu 2Health News:Four of Five Families Will Be Touched by Stroke in 2009 2
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... -- Every day, their baby stopped breathing, his collapsed bronchus blocking ... April and Bryan Gionfriddo watched helplessly, just praying ... a few doctors said he had a good chance of ... , about her now 20-month-old son, Kaiba. "At that ... take it and run with it." They found ...
(Date:5/23/2013)... May 23, 2013   Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...
Breaking Medicine Technology:Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3
... The epicenter of the technology world moves to Basking Ridge, ... the Korean Trade-Investment Promotion Agency (KOTRA), kicks off later this ... it brings together companies seeking the most innovative and creative ... October 26th at 8:30AM EDT (US & Canada) at the ...
... ReVision Therapeutics Inc. today announced results from a ... slows lesion growth and preserves visual acuity in patients ... dry age-related macular degeneration ( AMD ). The data ... (RBP) levels of 60 percent to 75 percent was ...
Cached Medicine Technology:Top U.S. and Korean Companies to Converge at 2010 Global Partnering Day 2Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients 2Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients 3
... All toggle switches at off (center position) , Double ... by .75 s; repeats every 10 s , Twitch: ... Tetanus: 50 Hz (50 pulses/s) or 100 Hz (100 ... pulses/2 s; repeats every 10 s) , Output Current: ...
... of Operation: , Standby: All toggle switches at ... (1 pulse/s); 10 s (1 pulses/10 s) , ... (100 pulses/s) , Train-Of-Four: Single (4 pulses/2 s); ... , Output Current: Adjustable from 0-70 mA(HI range) ...
... Modes of Operation: , Double Burst : 2 ... , Twitch: 1 s (1 pulse/s) , Tetanus: ... , Train-Of-Four: Single (4 pulses/2 s) , Output ... Square Wave Monophasic pulses (200-us duration) , Indicators: Battery ...
... A standby switch maintains power to the instrument ... (1 pulse/s) , Tetanus: 100 Hz (200 ... Output Current: Adjustable from 0-70 mA , ... , Indicators: Battery LED (green) indicates that the ...
Medicine Products: